Literature DB >> 11354349

Relationship between meniscal degeneration and element contents.

T Habata1, H Ohgushi, Y Takakura, Y Tohno, Y Moriwake, T Minami, Y Fujisawa.   

Abstract

The purpose of this study is to investigate the relationship between meniscal degeneration and element contents. The contents of elements (calcium, phosphorus, sulfur, and magnesium) in the menisci from 17 patients with osteoarthritis (OA) of the knee, 6 with rheumatoid arthritis (RA), and 2 who underwent the surgical operation for malignant tumors (control) were analyzed by inductively coupled plasma-atomic emission spectrometry, and the menisci were divided into four stages (Stage 0-3) of histological degeneration. The calcium contents of the menisci were 0.26 +/- 0.16 in Stage 0, 0.50 +/- 0.37 in Stage 1, and 0.69 +/- 0.66 in Stage 2, respectively (the values represent mg elements/g dry tissue). They increased with the progression of the stage. This tendency was found in the menisci with OA, but was not clear in those with RA. The calcium content in the control group was 0.17 +/- 0.09 mg/g. There was no significant relationship between the stage of degeneration and the contents of phosphorus, sulfur, or magnesium. The calcium content of the meniscus might indicate the degree of meniscal degeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354349     DOI: 10.1385/BTER:79:3:247

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  3 in total

Review 1.  Histological scoring systems for tissue-engineered, ex vivo and degenerative meniscus.

Authors:  Umile Giuseppe Longo; Mattia Loppini; Giovanni Romeo; Nicola Maffulli; Vincenzo Denaro
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-07-26       Impact factor: 4.342

2.  Analysis of meniscal degeneration and meniscal gene expression.

Authors:  Yubo Sun; David R Mauerhan; Patrick R Honeycutt; Jeffrey S Kneisl; James H Norton; Edward N Hanley; Helen E Gruber
Journal:  BMC Musculoskelet Disord       Date:  2010-01-28       Impact factor: 2.362

3.  Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis.

Authors:  Yubo Sun; David R Mauerhan; Atiya M Franklin; James Norton; Edward N Hanley; Helen E Gruber
Journal:  Biomed Res Int       Date:  2013-02-21       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.